Resectable Melanoma: Assessing Pathological Response Following Neoadjuvant Treatment
 
This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving the measurement, scoring, and assessment of pathological response in patients with resectable melanoma undergoing neoadjuvant immunotherapy.
 
Course topics include:

• Measurement and scoring of pathologic response in resectable melanoma
• Best practices for specimen collection and handling
• Immunotherapy-related pathologic response scoring systems to assess pathologic response 

Faculty/Authors
Janis Marie Taube, M.D., M.Sc.
Director, Division of Dermatopathology
Professor of Dermatology, Pathology, and Oncology  
Johns Hopkins University School of Medicine 

Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
 
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement

CME/CMLE Credit: 0.5
Estimated Completion Time: 0.5 hour
Format: Online educational activity

Credit Designation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
 
The ASCP designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
 
ASCP designates this activity for a maximum of 0.5 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.
 
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.
 
Commercial Support
This activity is funded by an independent educational grant from Bristol Myers Squibb.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

1. Review the Technical Considerations.
2. Click Go to Content and click the first module of the course.
3. Complete the Demographic Survey.
4. Complete the Pre-Test.
5. Review the Educational Activity.
6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
7. Submit the course Evaluation.
8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Upon completion of this activity, you will be able to:

• Discuss the measurement and scoring of pathologic response in resectable melanoma

• Describe best practices for specimen collection and handling to ensure the accurate measurement of pathologic response

• Utilize established immunotherapy-related pathologic response scoring systems to assess pathologic response in patients with resectable melanoma undergoing neoadjuvant immunotherapy